Blog

Importante convocatoria de la Federación Mundial de Asociaciones de Salud Pública (WFPHA)

La Federación Mundial de Asociaciones de Salud Pública (WFPHA) invita a todas aquellas personas con experiencia en participación social, abogacía en salud pública y defensa de derechos e intereses comunitarios a compartir sus vivencias. Esta convocatoria busca recopilar y destacar casos significativos a través del "Casebook on Advocacy in Public Health".

El Casebook aceptará contribuciones en dos categorías: casos completos de abogacía con evaluación de impacto, y acciones innovadoras únicas que, debido a su naturaleza especial, pueden promover la salud pública. La Editorial revisará las propuestas considerando la relevancia con los objetivos del Casebook, la claridad en la presentación, la aplicabilidad en diversos contextos, la alineación con los Objetivos de Desarrollo Sostenible y la representación global.

Los casos serán evaluados por expertos seleccionados por los editores, y abordarán cuestiones cruciales en todas las presentaciones, como la descripción cautivadora de la experiencia en abogacía en salud pública, el análisis del problema de salud pública, el contexto socioeconómico, la evaluación de procedimientos y la reflexión sobre fortalezas y debilidades.

Te invitamos a formar parte de esta iniciativa valiosa que busca aprender de experiencias pasadas para avanzar en políticas de salud pública a nivel local, regional, nacional e internacional. ¡Participá y compartí tu perspectiva para contribuir al fortalecimiento de la salud global!

 

INSCRIPCIÓN AQUÍ

 

A CONTINUACIÓN COMPARTIMOS LA CONVOCATORIA ORIGINAL

Casebook on Advocacy in Public Health

GUIDELINES FOR CONTRIBUTORS

Editorial procedures:

Submissions are welcome in the following categories:

- 1. Full advocacy cases (3000 words). Manuscripts accepted for this section should describe advocacy interventions that have been evaluated and provide information on their impact.

- 2. Unique innovative advocacy actions (1600 words). This section will accept short manuscripts describing advocacy actions that, due to their unique nature, may be of interest to promote public health regardless of whether they have been evaluated or not. Examples include novel actions that achieve community mobilisation to improve health, imaginative actions in the use of the media to get an issue into the news or onto the political agenda or successful intervention in public health policy through meetings with decision-makers. 

The Editorial Committee will review all manuscripts received based on the extent to which they address the following criteria:

1. Relevance to the objectives and intended audiences of the Casebook, in particular all cases should address the following overarching question: What lessons can be drawn from your experience that can advance public health policies at local, regional, nation or international level? We are interested in lessons learned from the advocacy case for researchers, funders, practitioners, policy makers, civil society organisations and others.

2. Clarity of case presentation for the intended audiences.

3. Applicability of the advocacy action in diverse contexts.

4. The alignment of the case with the Sustainable Development Goals.

5. Representation of cases from all global regions and from multiple countries across all income levels.

Manuscripts will be peer-reviewed by experts determined by the Editors.

Issues to be addressed in all submissions:

The manuscript should provide an engaging description of an experience in public health advocacy.

Given that advocacy is essentially related to stimulating action in the public health arena, the cases should be focussed on policy and/or practice. However, teaching and learning experiences that are directly related to public health actions as well as cases based on intersectional collaborations that promote alliances with relevant population health key actors (trade unions, local religious organizations, sport clubs, etc) are acceptable. In addition, historical cases when particularly relevant are also welcome.

More specifically, the manuscript should:

• Describe the public health problem (population affected; burden of disease associated with the problem and its costs) and the socio-economic context of the problem (heterogeneity of the problem in the population, its determinants and impact).

 

c/o Institute of Global Health • University of Geneva, Campus Biotech - G6 • Chemin des Mines 9, 1202 Geneva • Switzerland • www.wfpha.org

 

• Analyse the policy context and the rationale used by civil society, the government, and other stakeholders to defend the advocacy action.

• Identify the goal of the advocacy action and the decision makers involved to accomplish the goal (i.e., the target of the advocacy action).

• Consider the role of opinion setters and their credibility. Assess what type of evidence or explanation is needed to persuade these opinion setters and society as a whole.

• Describe the evaluation procedures.

• Identify the challenges and the type(s) of advocacy strategy selected.

• Reflect on the strengths and weaknesses of the advocacy experience described with comparisons to similar cases, if appropriate, and suggestions for future actions.

 

INDICATIONS FOR AUTHORS. Manuscript preparation and submission

1. FULL ADVOCACY CASES:

 

The final manuscripts should not exceed 3000 words (tables and figures excluded) and must include the following components:

− Page numbers.

− The text should use 1.5 spacing in A4 (not US Letter), Times New Roman with a font size of 12.

− Pages and lines in pages need to be numbered throughout the text of the manuscript to facilitate the identification by editors and reviewers of the specific places in the manuscript that

the author needs to address. To number lines in Word: > Page Setup > Line Numbers > Continuous.

− Tables, figures, images, and photos should be uploaded as separate files, containing the corresponding titles and footnotes.

− All headings and sub-headings should be in bold with levels clearly distinguished.

− Sensitive information, such as stakeholder names, should be anonymised.

The manuscript must follow the next structure:

o First page including:

- Title of the manuscript

- Author names

- Author affiliations

- Contact information for the corresponding author

- Acknowledgements o Second page: the structured abstract of up to 250 words.

o Background up to 750 words covering the following issues:

- Brief introduction to the case providing information about how the advocacy action

was developed and other relevant contextual information to orient the reader to the

policy situation and political environment.

- Clear articulation of the policy challenge including the opponents and their influence.

- How the evaluation was done, the results obtained, and the impact achieved.

 

3

 

c/o Institute of Global Health • University of Geneva, Campus Biotech - G6 • Chemin des Mines 9, 1202 Geneva • Switzerland • www.wfpha.org

 

o Body of the full case up to 1500 words including the design, implementation, evaluation, and

impact of the advocacy action applied. The following issues should be addressed: the kind of

intervention executed, how the advocacy action was developed and evaluated,

communication strategy employed, the main actors and opponent actors involved, the

recipient of the action and the alliances created, if any.

o Discussion up to 750 words, including:

- Lessons learned.

- Potential improvements in the future.

- Applicability of the action in other contexts or with other purposes.

- Implications for policy, practice, and research.

o Key messages for public health advocacy box

The authors should introduce lessons learned from the implementation of the public health

advocacy action. Specifically, it could include some of the key steps, learnings, and tips, either

using short texts or an illustrative image.

o Policy implications box

The policy implications of the action should be summarised in 2 or 3 bullet points using short

distinct sentences which will be formatted within a box in the published case.

o The References should follow the Vancouver style, developed by the International

Committee of Medical Journal Editors (ICJME) and consisting of:

- Citations to someone else’s work in the text, indicated using a number.

- A sequentially numbered reference list at the end of the document providing full

details of the corresponding in-text references.

See https://www.icmje.org/recommendations/

o Tables and figures: up to 4, combined, should be submitted in an independent file. Tables must

be simple and self-contained, with a description of the content. Figures must be of print

quality resolution 300 dpi minimum with a 150-line screen.

o Images and photos: up to 3, should be submitted as independent files. Any submitted image

must be of print quality resolution 300 dpi minimum with a 150-line screen. If people appear in

the images, authors must submit a statement that confirms that written informed consent for

publication was obtained.

Manuscripts must be submitted before 31 March 2024 in a Word document format to the

following Google Form url: https://shorturl.at/ekqx0

A first triage will be conducted by the Editors to identify manuscripts of sufficient priority. After the

initial triage, manuscripts will be peer-reviewed.

 

4

 

c/o Institute of Global Health • University of Geneva, Campus Biotech - G6 • Chemin des Mines 9, 1202 Geneva • Switzerland • www.wfpha.org

 

2. UNIQUE INNOVATIVE ADVOCACY ACTIONS:

The final manuscripts should be no more than 1600 words (excluding tables and figures) and must

contain the following elements:

− Page numbers.

− The text should use 1.5 spacing in A4 (not US Letter), Times New Roman with a font size of 12.

− Pages and lines in pages need to be numbered throughout the text of the manuscript to

facilitate the identification by editors and reviewers of the specific places in the manuscript that

the author needs to address. To number lines in Word: > Page Setup > Line Numbers >

Continuous.

− Tables, figures, images, and photos should be uploaded as separate files, containing the

corresponding titles and footnotes.

− All headings and sub-headings should be in bold with levels clearly distinguished.

− Sensitive information, such as stakeholder names, should be anonymised.

The manuscript must follow the next structure:

o First page including:

- Title of the manuscript

- Author names

- Author affiliations

- Contact information for the corresponding author

- Acknowledgements

o Second page: structured abstract that must contain up to 200 words.

o Background up to 400 words covering the following issues:

- Brief introduction to the case providing information about the public health issue

wanted to address, the barriers and opportunities for doing so, and some background

on previous actions in the same or other contexts that helped them to devise the

action.

 

o Description of the advocacy action up to 1200 words describing the kind of intervention

executed, how the advocacy action was developed and the reasons that make it an illustrative

advocacy initiative to be emulated.

o Key messages for public health advocacy box

- Same indications as for full cases.

o Policy implications box

- Same indications as for full cases.

o Conclusions up to 400 words, including:

- Lessons learned and policy implications.

 

5

 

c/o Institute of Global Health • University of Geneva, Campus Biotech - G6 • Chemin des Mines 9, 1202 Geneva • Switzerland • www.wfpha.org

 

- Potential improvements in the future and next steps in the advocacy strategy.

o References. Same indications as for full cases.

o Tables and figures: up to 2, combined. Same indications as for full cases.

o Images and photos: up to 3. Same indications as for full cases.

 

Manuscripts must be submitted before 31 March 2024 in a Word document format to the

following Google Form url: https://shorturl.at/ekqx0

A first triage will be conducted by the Editors to ensure manuscripts are relevant to the casebook

 

objectives and adhere to editorial guidelines. After the initial triage, manuscripts will be peer-

reviewed.

 

If you have any questions or comments, please let us know to the email Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo. Attn

Clara Blanes, managing editor.

 

AUTHORSHIP AND CONTRIBUTORS’ RESPONSIBILITIES

o Cases with multiple authors should allocate one person as the lead author for communication

with the Casebook Editors (“corresponding author”).

o To attribute authorship, contributors are encouraged to refer to international guidelines (e.g.,

 

http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-

role-of-authors-and-contributors.html)

 

o Contributors must do the following:

- Abide by high standards of rigorous and robust research integrity and good

scholarship.

- Submit well-written articles which are factually correct.

- Acknowledge the contributions of third parties when applicable,

- Obtain permission to use copyrighted material.

- Ensure that the details provided in their submissions do not infringe upon or violate

any pre-existing agreements to privacy or confidentiality between the parties

involved in the collaboration described.

- State whether the article has previously been published or is simultaneously under

consideration with a journal. Note: previously published case studies may be

considered provided they meet the relevant copyright rules.

- Agree to make revisions requested by the Editors following the peer review process.

©2024 Asociación Argentina de Salud Pública

Search

Comprar Viagra Oviedo en España Comprar Zitromax sin receta Comprar Topamax sin receta